Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Bionano Genomics has disclosed Debt Ratio across 7 years of filings, most recently posting 0.05 for Q3 2023.

• Debt Ratio for Q3 2023 came in at 0.05, up 91.28% year-over-year; the trailing twelve-month figure through Sep 2023 was 0.05 (up 91.28% YoY), and the FY2022 annual result was 0.03, changed N/A from the prior year.
• Debt Ratio came in at 0.05 for Q3 2023 at Bionano Genomics, up from 0.04 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.03 in Q3 2019 to a low of 0.03 in Q2 2022.
• The 5-year median for Debt Ratio is 0.27 (2020), against an average of 0.36.
• Across the five-year window, Debt Ratio jumped 249.73% in 2019 and plunged 95.65% in 2021, its largest moves.
• Bionano Genomics' Debt Ratio stood at 0.66 in 2019, then tumbled by 59.38% to 0.27 in 2020, then tumbled by 85.7% to 0.04 in 2021, then slipped by 21.01% to 0.03 in 2022, then surged by 80.18% to 0.05 in 2023.
• The last three Debt Ratio figures came in at 0.05 (Q3 2023), 0.04 (Q2 2023), and 0.03 (Q1 2023), per Business Quant data.